Logo image of CCL

CARNIVAL CORP (CCL) Stock Fundamental Analysis

NYSE:CCL - New York Stock Exchange, Inc. - PA1436583006 - Common Stock - Currency: USD

19.255  +0.63 (+3.35%)

Fundamental Rating

4

Overall CCL gets a fundamental rating of 4 out of 10. We evaluated CCL against 136 industry peers in the Hotels, Restaurants & Leisure industry. There are concerns on the financial health of CCL while its profitability can be described as average. A decent growth rate in combination with a cheap valuation! Better keep an eye on CCL.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CCL had positive earnings in the past year.
In the past year CCL had a positive cash flow from operations.
CCL had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CCL reported negative operating cash flow in multiple years.
CCL Yearly Net Income VS EBIT VS OCF VS FCFCCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

CCL has a Return On Assets of 4.23%. This is in the better half of the industry: CCL outperforms 65.44% of its industry peers.
CCL has a better Return On Equity (22.35%) than 80.88% of its industry peers.
With a decent Return On Invested Capital value of 8.21%, CCL is doing good in the industry, outperforming 66.18% of the companies in the same industry.
Industry RankSector Rank
ROA 4.23%
ROE 22.35%
ROIC 8.21%
ROA(3y)-2.68%
ROA(5y)-8.99%
ROE(3y)-22.2%
ROE(5y)-38.93%
ROIC(3y)N/A
ROIC(5y)N/A
CCL Yearly ROA, ROE, ROICCCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

Looking at the Profit Margin, with a value of 8.07%, CCL is in the better half of the industry, outperforming 67.65% of the companies in the same industry.
CCL's Profit Margin has declined in the last couple of years.
CCL has a Operating Margin of 15.11%. This is in the better half of the industry: CCL outperforms 66.18% of its industry peers.
CCL's Operating Margin has declined in the last couple of years.
CCL has a better Gross Margin (53.19%) than 64.71% of its industry peers.
CCL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.11%
PM (TTM) 8.07%
GM 53.19%
OM growth 3YN/A
OM growth 5Y-1.91%
PM growth 3YN/A
PM growth 5Y-11.81%
GM growth 3YN/A
GM growth 5Y6.74%
CCL Yearly Profit, Operating, Gross MarginsCCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1

2. Health

2.1 Basic Checks

CCL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CCL has more shares outstanding than it did 1 year ago.
CCL has more shares outstanding than it did 5 years ago.
CCL has a better debt/assets ratio than last year.
CCL Yearly Shares OutstandingCCL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
CCL Yearly Total Debt VS Total AssetsCCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

CCL has an Altman-Z score of 1.00. This is a bad value and indicates that CCL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.00, CCL is not doing good in the industry: 65.44% of the companies in the same industry are doing better.
The Debt to FCF ratio of CCL is 13.60, which is on the high side as it means it would take CCL, 13.60 years of fcf income to pay off all of its debts.
CCL has a Debt to FCF ratio (13.60) which is comparable to the rest of the industry.
CCL has a Debt/Equity ratio of 2.78. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CCL (2.78) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 2.78
Debt/FCF 13.6
Altman-Z 1
ROIC/WACC1
WACC8.21%
CCL Yearly LT Debt VS Equity VS FCFCCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

A Current Ratio of 0.26 indicates that CCL may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.26, CCL is doing worse than 91.91% of the companies in the same industry.
CCL has a Quick Ratio of 0.26. This is a bad value and indicates that CCL is not financially healthy enough and could expect problems in meeting its short term obligations.
CCL's Quick ratio of 0.21 is on the low side compared to the rest of the industry. CCL is outperformed by 93.38% of its industry peers.
Industry RankSector Rank
Current Ratio 0.26
Quick Ratio 0.21
CCL Yearly Current Assets VS Current LiabilitesCCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

CCL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 385.29%, which is quite impressive.
CCL shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.70% yearly.
The Revenue has grown by 12.66% in the past year. This is quite good.
Measured over the past years, CCL shows a small growth in Revenue. The Revenue has been growing by 3.74% on average per year.
EPS 1Y (TTM)385.29%
EPS 3YN/A
EPS 5Y-20.7%
EPS Q2Q%192.86%
Revenue 1Y (TTM)12.66%
Revenue growth 3Y135.82%
Revenue growth 5Y3.74%
Sales Q2Q%7.47%

3.2 Future

CCL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.55% yearly.
CCL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.12% yearly.
EPS Next Y36.11%
EPS Next 2Y25.04%
EPS Next 3Y22.09%
EPS Next 5Y18.55%
Revenue Next Year4.49%
Revenue Next 2Y4.11%
Revenue Next 3Y3.9%
Revenue Next 5Y4.12%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CCL Yearly Revenue VS EstimatesCCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B
CCL Yearly EPS VS EstimatesCCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2 4 -4 -6

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.67 indicates a reasonable valuation of CCL.
Based on the Price/Earnings ratio, CCL is valued cheaply inside the industry as 86.76% of the companies are valued more expensively.
CCL is valuated cheaply when we compare the Price/Earnings ratio to 27.75, which is the current average of the S&P500 Index.
CCL is valuated reasonably with a Price/Forward Earnings ratio of 8.92.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CCL indicates a rather cheap valuation: CCL is cheaper than 88.97% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.49. CCL is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.67
Fwd PE 8.92
CCL Price Earnings VS Forward Price EarningsCCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CCL indicates a somewhat cheap valuation: CCL is cheaper than 76.47% of the companies listed in the same industry.
83.09% of the companies in the same industry are more expensive than CCL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.72
EV/EBITDA 7.86
CCL Per share dataCCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CCL's earnings are expected to grow with 22.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y25.04%
EPS Next 3Y22.09%

0

5. Dividend

5.1 Amount

No dividends for CCL!.
Industry RankSector Rank
Dividend Yield N/A

CARNIVAL CORP

NYSE:CCL (5/2/2025, 10:53:07 AM)

19.255

+0.63 (+3.35%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)03-21 2025-03-21/bmo
Earnings (Next)06-23 2025-06-23/amc
Inst Owners62.46%
Inst Owner Change-0.31%
Ins Owners7.57%
Ins Owner Change0.38%
Market Cap25.26B
Analysts80.63
Price Target28.5 (48.01%)
Short Float %5.57%
Short Ratio2.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)307.47%
Min EPS beat(2)83.06%
Max EPS beat(2)531.88%
EPS beat(4)4
Avg EPS beat(4)345.5%
Min EPS beat(4)8.2%
Max EPS beat(4)758.87%
EPS beat(8)8
Avg EPS beat(8)184.17%
EPS beat(12)10
Avg EPS beat(12)96.34%
EPS beat(16)10
Avg EPS beat(16)67.36%
Revenue beat(2)1
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.88%
Max Revenue beat(2)0.05%
Revenue beat(4)2
Avg Revenue beat(4)-0.05%
Min Revenue beat(4)-0.88%
Max Revenue beat(4)0.75%
Revenue beat(8)5
Avg Revenue beat(8)0.32%
Revenue beat(12)6
Avg Revenue beat(12)-2.18%
Revenue beat(16)6
Avg Revenue beat(16)-10.24%
PT rev (1m)-4.3%
PT rev (3m)1.47%
EPS NQ rev (1m)0.37%
EPS NQ rev (3m)9.8%
EPS NY rev (1m)1.66%
EPS NY rev (3m)6.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)0.34%
Revenue NY rev (3m)0.28%
Valuation
Industry RankSector Rank
PE 11.67
Fwd PE 8.92
P/S 0.99
P/FCF 12.72
P/OCF 4.97
P/B 2.75
P/tB 3.4
EV/EBITDA 7.86
EPS(TTM)1.65
EY8.57%
EPS(NY)2.16
Fwd EY11.2%
FCF(TTM)1.51
FCFY7.86%
OCF(TTM)3.87
OCFY20.11%
SpS19.38
BVpS7
TBVpS5.67
PEG (NY)0.32
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.23%
ROE 22.35%
ROCE 10.4%
ROIC 8.21%
ROICexc 8.4%
ROICexgc 8.83%
OM 15.11%
PM (TTM) 8.07%
GM 53.19%
FCFM 7.81%
ROA(3y)-2.68%
ROA(5y)-8.99%
ROE(3y)-22.2%
ROE(5y)-38.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-0.03%
ROICexc growth 3YN/A
ROICexc growth 5Y1.43%
OM growth 3YN/A
OM growth 5Y-1.91%
PM growth 3YN/A
PM growth 5Y-11.81%
GM growth 3YN/A
GM growth 5Y6.74%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 2.78
Debt/FCF 13.6
Debt/EBITDA 3.96
Cap/Depr 119.13%
Cap/Sales 12.17%
Interest Coverage 250
Cash Conversion 78.9%
Profit Quality 96.78%
Current Ratio 0.26
Quick Ratio 0.21
Altman-Z 1
F-Score7
WACC8.21%
ROIC/WACC1
Cap/Depr(3y)178.87%
Cap/Depr(5y)171.94%
Cap/Sales(3y)24.77%
Cap/Sales(5y)65.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)385.29%
EPS 3YN/A
EPS 5Y-20.7%
EPS Q2Q%192.86%
EPS Next Y36.11%
EPS Next 2Y25.04%
EPS Next 3Y22.09%
EPS Next 5Y18.55%
Revenue 1Y (TTM)12.66%
Revenue growth 3Y135.82%
Revenue growth 5Y3.74%
Sales Q2Q%7.47%
Revenue Next Year4.49%
Revenue Next 2Y4.11%
Revenue Next 3Y3.9%
Revenue Next 5Y4.12%
EBIT growth 1Y59.82%
EBIT growth 3YN/A
EBIT growth 5Y1.76%
EBIT Next Year90.99%
EBIT Next 3Y28.88%
EBIT Next 5Y18.36%
FCF growth 1Y159.2%
FCF growth 3YN/A
FCF growth 5Y94.16%
OCF growth 1Y7358.57%
OCF growth 3YN/A
OCF growth 5Y1.58%